{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:08:06Z","timestamp":1789214886992,"version":"build-2803163510"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.revmed.2026.08.016","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:25:17Z","timestamp":1789212317000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chez des patients avec ad\u00e9nocarcinome pancr\u00e9atique m\u00e9tastatique d\u00e9j\u00e0 trait\u00e9, est-ce que le daraxonrasib am\u00e9liore la survie globale et la survie sans progression comparativement \u00e0 une chimioth\u00e9rapie standard, tout en \u00e9tant s\u00e9curitaire\u00a0?"],"prefix":"10.1016","author":[{"given":"Luc","family":"Lanthier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mutchmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-\u00c9mile","family":"Plourde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Cauchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10485","key":"10.1016\/j.revmed.2026.08.016_bib0045","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.revmed.2026.08.016_bib0050","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36\u00a0cancers in 185\u00a0countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.revmed.2026.08.016_bib0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","article-title":"Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer","volume":"17","author":"Buscail","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"18","key":"10.1016\/j.revmed.2026.08.016_bib0060","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1056\/NEJMe2600517","article-title":"Advances in RAS therapeutics for pancreatic cancer","volume":"394","author":"Der","year":"2026","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.revmed.2026.08.016_bib0065","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa2505783","article-title":"Daraxonrasib in previously treated advanced RAS-mutated pancreatic cancer","volume":"394","author":"Wolpin","year":"2026","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.revmed.2026.08.016_bib0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2605555","article-title":"Daraxonrasib or chemotherapy in previously treated metastatic pancreatic cancer","volume":"395","author":"O\u2019Reilly","year":"2026","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.revmed.2026.08.016_bib0075","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1056\/NEJMe2606948","article-title":"Breaking the RAS barrier in pancreatic cancer","volume":"395","author":"Sivakumar","year":"2026","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.revmed.2026.08.016_bib0040","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1038\/s41591-026-04537-w","article-title":"Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer","volume":"32","author":"Aronchik","year":"2026","journal-title":"Nat Med"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326007265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326007265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:25:19Z","timestamp":1789212319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866326007265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":8,"alternative-id":["S0248866326007265"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2026.08.016","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chez des patients avec ad\u00e9nocarcinome pancr\u00e9atique m\u00e9tastatique d\u00e9j\u00e0 trait\u00e9, est-ce que le daraxonrasib am\u00e9liore la survie globale et la survie sans progression comparativement \u00e0 une chimioth\u00e9rapie standard, tout en \u00e9tant s\u00e9curitaire\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2026.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}